Featured Research

from universities, journals, and other organizations

Source of mystery pain uncovered

Date:
June 22, 2011
Source:
Yale University
Summary:
Scientists have found that mutations of a single gene are linked to 30 percent of cases of unexplained neuropathy.

An estimated 20 million people in the United States suffer from peripheral neuropathy, marked by the degeneration of nerves and in some cases severe pain. There is no good treatment for the disorder and doctors can find no apparent cause in one of every three cases.

An international team of scientists headed by researchers from Yale University, the Veterans Affairs Medical Center in West Haven and the University Maastricht in the Netherlands found that mutations of a single gene are linked to 30 percent of cases of unexplained neuropathy. The findings, published online June 22 in the Annals of Neurology, could lead to desperately needed pain treatments for victims of this debilitating disorder.

"For millions of people, the origin of this intense pain has been a frustrating mystery," said Stephen Waxman, the Bridget Marie Flaherty Professor of Neurology and professor of neurobiology and of pharmacology and a senior co-author of the paper. "All of us were surprised to find that these mutations occur in so many patients with neuropathy with unknown cause."

The study focused upon mutations of a single gene -- SCNA9 -- which is expressed in sensory nerve fibers. Waxman's group had discovered that mutations in this gene's product -- the protein sodium channel Nav1.7 -- cause a rare disorder called "Man on Fire Syndrome," characterized by excruciating and unrelenting pain. Colleagues in the Netherlands carefully scrutinized neuropathy patients to rule out all known causes of the neuropathy, such as diabetes, alcoholism, metabolic disorders and exposure to toxins. Researchers then did a genetic analysis of 28 patients with neuropathy with no known cause. They found 30 percent of these subjects had mutations in the SCN9A gene. The researchers found that the mutations cause nerve cells to become hyperactive, a change they believe eventually leads to degeneration of nerve fibers.

"These findings will help us as clinicians to a better understanding of our patients with small fiber neuropathy and could ideally have implications for the development of future specific therapies," said Catharina G. Faber, who is a lead author of the study along with Ingemar Merkies of the Netherlands.

Other Yale authors of the paper are Hye-Sook Ahn, Chongyang, Han, Xiaoyang Cheng, Jin-Sung Choi, Mark Estacion and Sulayman Dib-Hajj.

The research was funded by the Department of Veterans Affairs, The Erythromelalgia Association (USA) and by the Profileringsfonds of University of Maastricht, The Netherlands.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Catharina G. Faber, Janneke G.J. Hoeijmakers, Hye-Sook Ahn, Xiaoyang Cheng, Chongyang Han, Jin-Sung Choi, Mark Estacion, Giuseppe Lauria, Els K. Vanhoutte, Monique M. Gerrits, Sulayman Dib-Hajj, Joost P.H. Drenth, Stephen G. Waxman, Ingemar S.J. Merkies. Gain-of-function NaV1.7 mutations in idiopathic small fiber neuropathy. Annals of Neurology, 2011; DOI: 10.1002/ana.22485

Cite This Page:

Yale University. "Source of mystery pain uncovered." ScienceDaily. ScienceDaily, 22 June 2011. <www.sciencedaily.com/releases/2011/06/110622125656.htm>.
Yale University. (2011, June 22). Source of mystery pain uncovered. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2011/06/110622125656.htm
Yale University. "Source of mystery pain uncovered." ScienceDaily. www.sciencedaily.com/releases/2011/06/110622125656.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins